{
  "study_id": "10.1136/bmjopen-2017-017593",
  "study_characteristics": {
    "title": "Health economic evaluation of a serum-based blood test for brain tumour diagnosis: exploration of two clinical scenarios",
    "design": "Model-based health pre-trial economic assessment (decision tree model)",
    "sample_size": 10000,
    "sample_size_by_group": [
      {
        "group": "Intervention",
        "n": 10000
      },
      {
        "group": "Comparator",
        "n": 10000
      }
    ],
    "follow_up_duration_month": 24.0,
    "publication_year": 2018,
    "geographic_location": "UK and USA",
    "journal_name": "BMJ Open",
    "author_info": {
      "primary_author": "Ewan Gray",
      "primary_author_email": "matthew.baker@strath.ac.uk",
      "affiliation": "Multiple institutions"
    },
    "funding_source": {
      "source": "Not Available",
      "details": "Scottish Enterprise economic development agency"
    }
  },
  "population": {
    "name": "Symptomatic patients with non-specific symptoms (e.g., headache, dizziness)",
    "condition": "Brain tumour",
    "N": 10000,
    "disease_classification": {
      "name": "Brain tumour",
      "severity": "Malignant"
    },
    "target_population_age": "Not Available",
    "target_population_characteristics": "Patients at risk of brain tumours presenting with non-specific symptoms"
  },
  "interventions": [
    {
      "group": "Serum-based spectroscopic test",
      "treatment": "Blood-based spectroscopic triage tool",
      "dose": "Not specified",
      "freq": "Not specified",
      "route": "Blood test",
      "intervention_type": "diagnostic"
    },
    {
      "group": "Test group",
      "treatment": "ATR-FTIR spectroscopic test",
      "dose": "1–5 µL",
      "freq": "Not specified",
      "route": "blood serum",
      "intervention_type": "diagnostic"
    },
    {
      "group": "Intervention",
      "treatment": "Serum spectroscopic test",
      "dose": "Not specified",
      "freq": "Not specified",
      "route": "Blood-based",
      "intervention_type": "diagnostic"
    },
    {
      "group": "Spectroscopic test group",
      "treatment": "Spectroscopic serum test",
      "dose": "Not specified",
      "freq": "Not specified",
      "intervention_type": "diagnostic"
    },
    {
      "group": "Intervention",
      "treatment": "Serum spectroscopy test",
      "dose": "Not specified",
      "freq": "Not specified",
      "route": "Blood test",
      "intervention_type": "diagnostic"
    },
    {
      "group": "Serum spectroscopy test",
      "treatment": "Serum spectroscopy diagnostic test",
      "dose": "Not specified",
      "freq": "Not specified",
      "intervention_type": "diagnostic"
    },
    {
      "group": "Serum spectroscopy group",
      "treatment": "Serum spectroscopy test",
      "dose": "Not specified",
      "freq": "Not specified",
      "intervention_type": "diagnostic"
    },
    {
      "group": "Not Available",
      "treatment": "carmustine implants and temozolomide",
      "dose": "Not specified",
      "freq": "Not specified",
      "intervention_type": "pharmaceutical"
    }
  ],
  "comparators": [
    {
      "group": "Current diagnostic pathway",
      "standard_care": true,
      "comparator_type": "standard_care",
      "number_of_comparators": 1
    },
    {
      "group": "Standard care group",
      "treatment": "MRI and CT scans",
      "standard_care": true,
      "comparator_type": "standard_care"
    },
    {
      "group": "Comparator",
      "treatment": "Imaging alone",
      "standard_care": true,
      "comparator_type": "standard_care"
    },
    {
      "group": "No test group",
      "standard_care": true,
      "comparator_type": "standard_care"
    },
    {
      "group": "Comparator",
      "treatment": "Standard care",
      "placebo": false,
      "standard_care": true,
      "comparator_type": "standard_care",
      "number_of_comparators": 1
    },
    {
      "group": "Current practice without test",
      "treatment": "Standard imaging (CT/MRI)",
      "standard_care": true,
      "comparator_type": "standard_care"
    },
    {
      "group": "Current practice group",
      "treatment": "Current clinical practice",
      "standard_care": true,
      "comparator_type": "standard_care"
    },
    {
      "group": "Not Available",
      "standard_care": true,
      "comparator_type": "standard_care"
    }
  ],
  "economic_data": {
    "effectiveness_utility": {
      "utility_types": "EQ-5D (inferred)",
      "health_state_utilities": [
        {
          "health_state_name": "High-grade glioma",
          "utility_value": 0.89,
          "source": "Previous UK economic evaluation of glioblastoma treatment"
        }
      ]
    },
    "model_parameters": {
      "time_horizon_year": 2.0,
      "WTP_threshold": 30000.0,
      "time_horizon": "Not specified",
      "perspectives": [
        "healthcare_system",
        "healthcare_system",
        "healthcare_system",
        "healthcare_system"
      ],
      "sensitivity_analysis": true,
      "sensitivity_analysis_type": [
        "one_way",
        "probabilistic",
        "scenario",
        "one_way",
        "one_way",
        "probabilistic"
      ],
      "cost_effectiveness_thresholds": [
        20000.0,
        30000.0,
        20000.0,
        30000.0,
        30000.0
      ],
      "model_type": "decision tree"
    },
    "icer_analysis": {
      "icer_value": 8840.0,
      "number_of_ratios": 4,
      "ratio_quadrant": "NE"
    },
    "currency_info": {
      "currency_country": "UK",
      "currency_year": 2015,
      "currency_code": "GBP"
    },
    "treatment_group_costs": [
      {
        "treatment_group": "Serum-based spectroscopic test",
        "cost_components": [
          {
            "component_name": "Test cost",
            "unit_cost": 40.0,
            "unit": "per test",
            "cost_category": "diagnostic",
            "source": "Assumption for cost-effectiveness",
            "cost_description": "Maximum price point for cost-effectiveness"
          }
        ]
      },
      {
        "treatment_group": "Current diagnostic pathway"
      },
      {
        "treatment_group": "Standard care group",
        "cost_components": [
          {
            "component_name": "MRI scan",
            "unit_cost": 164.0,
            "unit": "per scan",
            "cost_category": "diagnostic",
            "source": "National Schedule of Reference Costs (2014–2015)"
          },
          {
            "component_name": "CT scan",
            "unit_cost": 85.0,
            "unit": "per scan",
            "cost_category": "diagnostic",
            "source": "National Schedule of Reference Costs (2014–2015)"
          }
        ]
      },
      {
        "treatment_group": "Test group"
      },
      {
        "treatment_group": "Spectroscopic test group",
        "cost_components": [
          {
            "component_name": "Spectroscopic serum test",
            "cost_description": "Applied at upper/lower bounds (not commercialized)"
          },
          {
            "component_name": "MRI/CT imaging",
            "cost_description": "50% of negative tests continue to imaging (primary care)"
          },
          {
            "component_name": "Outpatient neurology visits",
            "source": "UK NHS reference costs"
          },
          {
            "component_name": "GP visits",
            "source": "PSSRU costs schedule"
          }
        ]
      },
      {
        "treatment_group": "No test group",
        "cost_components": [
          {
            "component_name": "MRI/CT imaging",
            "cost_description": "All patients receive imaging (secondary care)"
          },
          {
            "component_name": "Neurology referral",
            "cost_description": "Where imaging not available (primary care)"
          },
          {
            "component_name": "Outpatient visits",
            "source": "UK NHS reference costs"
          },
          {
            "component_name": "GP visits",
            "source": "PSSRU costs schedule"
          }
        ]
      },
      {
        "treatment_group": "Intervention",
        "cost_components": [
          {
            "component_name": "Serum spectroscopy test",
            "unit_cost": 50.0,
            "quantity": 1.0,
            "unit": "per test",
            "cost_category": "diagnostic",
            "source": "Assumed prices",
            "cost_per_patient": 50.0
          },
          {
            "component_name": "CT imaging study",
            "unit_cost": 85.0,
            "unit": "per study",
            "cost_category": "imaging",
            "source": "National Schedule of Reference Costs"
          },
          {
            "component_name": "MRI imaging study",
            "unit_cost": 164.0,
            "unit": "per study",
            "cost_category": "imaging",
            "source": "National Schedule of Reference Costs"
          },
          {
            "component_name": "Neurology outpatient appointment",
            "unit_cost": 35.0,
            "unit": "per appointment",
            "cost_category": "consultation",
            "source": "PSSRU"
          },
          {
            "component_name": "GP visit",
            "unit_cost": 47.25,
            "unit": "per visit",
            "cost_category": "consultation",
            "source": "PSSRU"
          }
        ]
      },
      {
        "treatment_group": "Comparator",
        "cost_components": [
          {
            "component_name": "CT imaging study",
            "unit_cost": 85.0,
            "unit": "per study",
            "cost_category": "imaging",
            "source": "National Schedule of Reference Costs"
          },
          {
            "component_name": "MRI imaging study",
            "unit_cost": 164.0,
            "unit": "per study",
            "cost_category": "imaging",
            "source": "National Schedule of Reference Costs"
          },
          {
            "component_name": "Neurology outpatient appointment",
            "unit_cost": 35.0,
            "unit": "per appointment",
            "cost_category": "consultation",
            "source": "PSSRU"
          },
          {
            "component_name": "GP visit",
            "unit_cost": 47.25,
            "unit": "per visit",
            "cost_category": "consultation",
            "source": "PSSRU"
          }
        ]
      },
      {
        "treatment_group": "Serum spectroscopy (Primary care)",
        "cost_components": [
          {
            "component_name": "Test cost",
            "unit_cost": 50.0,
            "unit": "per test",
            "cost_category": "diagnostic"
          }
        ]
      },
      {
        "treatment_group": "Serum spectroscopy (Secondary care)",
        "cost_components": [
          {
            "component_name": "Test cost",
            "unit_cost": 100.0,
            "unit": "per test",
            "cost_category": "diagnostic"
          }
        ]
      }
    ]
  },
  "outcomes": [
    {
      "name": "Diagnostic accuracy",
      "outcome_type": "primary",
      "time_point": "Diagnosis",
      "unit": "Percentage",
      "group_results": [
        {
          "group": "Serum-based spectroscopic test",
          "value": 92.8
        },
        {
          "group": "Serum-based spectroscopic test",
          "value": 91.5
        }
      ]
    },
    {
      "name": "Incremental QALYs",
      "outcome_type": "economic",
      "time_point": "lifetime",
      "unit": "QALYs per 10,000 patients",
      "group_results": [
        {
          "group": "Primary care (£50 test)",
          "value": 8.81
        },
        {
          "group": "Secondary care (£50 test)",
          "value": 10.153
        }
      ]
    },
    {
      "name": "Incremental costs",
      "outcome_type": "economic",
      "time_point": "lifetime",
      "unit": "GBP per 10,000 patients",
      "group_results": [
        {
          "group": "Primary care (£50 test)",
          "value": -1718475.0
        },
        {
          "group": "Secondary care (£50 test)",
          "value": 536702.0
        }
      ]
    }
  ]
}